Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC have?
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC has 2,828 citations in the OpenAlex counts ScholarIQ stores.
When was Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC published?
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC has 2018 year in the ScholarIQ index.
What is the open-access status of Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC?
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC has bronze oa status in the ScholarIQ index.
What is the DOI of Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC?
The DOI for Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC is on the source record.
What is the PMID of Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC?
The PMID for Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC is on the source record.
What is the OpenAlex record for Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC?
The OpenAlex for Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC is on the source record.